Table 3 Stability ranking of reference genes using geomean of ranking values analysed by three algorithms when prostate cells are treated with different DHT concentrations.

From: Identification of valid reference genes for mRNA and microRNA normalisation in prostate cancer cell lines

 

Group

Gene

All treatments

0 nM

1 nM

10 nM

100 nM

1000 nM

mRNAgene

AR+celllines

ACTB

1

1

3

2

5

1

GAPDH

2

4

6

3

4

5

YWHAZ

3

2

1

4

3

3

SDHA

4

5

2

1

2

4

TBP

5

3

4

6

6

6

K-ALPHA-1

6

7

8

5

1

8

18 S rRNA

7

6

5

9

9

9

ALAS1

8

8

7

7

7

2

RPL13A

9

9

9

8

8

7

HPRT1

10

10

10

10

10

10

The other cell lines

ACTB

1

1

5

1

2

1

HPRT1

2

4

1

4

3

2

SDHA

3

5

3

2

1

4

RPL13A

4

6

6

3

5

5

TBP

5

2

2

6

6

3

ALAS1

6

3

4

7

8

7

K-ALPHA-1

7

8

7

8

4

8

YWHAZ

8

7

8

9

9

6

GAPDH

9

9

9

5

10

10

18 S rRNA

10

10

10

10

7

9

npcRNAgene

AR+celllines

miR-16

1

2

1

2

3

1

miR-1228-3p

2

3

2

1

1

3

miR-1225-3p

3

1

4

3

2

2

RNU43

4

5

5

5

4

6

miR-130b

5

6

3

4

5

5

RNU6-2

6

4

6

6

6

4

The other cell lines

RNU6-2

1

1

2

2

1

2

RNU43

2

2

1

1

3

1

miR-1228-3p

3

5

4

3

4

6

miR-16

4

3

3

4

2

4

miR-1225-3p

5

4

6

6

5

3

miR-130b

6

6

5

5

6

5

  1. Cell lines were divided into two groups: AR+ cell lines (LNCaP and 22RV1), and AR− and normal cell lines (DU145, PC-3 and RWPE-1).